References
- Berman L D, Allison A C. Studies on murine sarcoma virus: a morphological comparison of tumor‐igenesis by the Harvey and Moloney strains in mice, and the establishment of tumor cell lines. Int J Cancer 1969; 4: 820–836
- Chirigos M A, Scott D, Turner W, Perk K. Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney). Int J Cancer 1968; 3: 223–227
- Gallick G E, Sparrow J T, Singh B, Maxwell S A, Stanker L H, Arlinghaus R B. Recognition of mos‐related proteins with an antiserum to a peptide of the v‐mos gene product. J Gen Virol 1985; 66: 945–955
- Gazdar A F, Chopra H C, Sarma P S. Properties of a murine sarcoma virus isolated from a tumor arising in an NZW.‐NZB F 1 hybrid mouse. I. Isolation and pathology of tumors induced in rodents. Int J Cancer 1972; 9: 219–233
- Hayashi Y, Tange T, Urano Y, Smadja‐Joffe F, Le Bousse‐Kerdiles M C, Jasmin C. Histopathologic studies on myeloproliferative sarcoma virus (MPSV) induced leukemias and hemangiosarcoma in Jar‐2 rats. Pathol Res Pract 1988; 183: 314–320
- Herzog N K, Nash M, Ramagli L S, Arlinghaus R B. v‐mos protein produced by in vitro translation has protein kinase activity. J Virol 1990; 64: 3093–3096
- Hubbard S R, Wei L, Ellis L, Hendrickson W A. Crystal structure of the tyrosine kinase domain of the human insulin receptor ‘see comments’. Nature 1994; 372: 746–754
- Knighton D R, Zheng J, Ten Eyck L F, Ashford V A, Xuong N H, Taylor S S, Sowadski J M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate‐dependent protein kinase. Science 1991a; 253: 407–414
- Knighton D R, Zheng J, Ten Eyck L F, Xuong N H, Taylor S S, Sowadski J M. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate‐dependent protein kinase. Science 1991b; 253: 414–420
- Kozak M. An analysis of 5′‐noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125–8148
- Le Bousse‐Kerdiles M C, Smadja‐Joffe F, Klein B, Caillou B, Jasmin C. Study of a virus‐induced myeloproliferative syndrome associated with tumor formation in mice. Eur J Cancer 1980; 16: 43–51
- Lim K Y, Ryan E A, Wong P K Y, Yuen P H. Studies on the pathology, especially brain hemorrhage and angioendotheliomas, induced by two new mos‐con‐taining viruses. J NeuroVirology 2000; 6, (in press)
- Mann R, Mulligan R C, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper‐free defective retrovirus. Cell 1983; 33: 153–159
- Moloney J B. A virus‐induced rhabdomyosarcoma of mice. Natl Cancer Inst Monogr 1966; 22: 139–142
- Ostertag W, Vehmeyer K, Fagg B, Pragnell I B, Paetz W, Le Bousse M C, Smadja‐Joffe F, Klein B, Jasmin C, Eisen H. Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus‐forming properties in adult mice. J Virol 1980; 33: 573–582
- Perk K, Moloney J B. Pathogenesis of a virus‐induced rhabdomyosarcoma in mice. J Natl Cancer Inst 1966; 37: 581–599
- Propst F, Cork L C, Kovatch R M, Kasenally A B, Wallace R, Rosenberg M P. Progressive hind limb paralysis in mice carrying a v‐Mos transgene. J Neuropathol Exp Neurol 1992; 51: 499–505
- Propst F, Rosenberg M P, Cork L C, Kovatch R M, Rauch S, Westphal H, Khillan J, Schulz N T, Neumann P E, Newmann P E. Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene. Proc Natl Acad Sci USA 1990; 87: 9703–9707, [published erratum appears in Proc Natl Acad Sci USA (1991) 88: 4060.]
- Ribacchi R, Giraldo G. Plasmacytomas occurring in the bones of rats injected intracerebrally with murine sarcoma virus (MSV), Moloney strain: preliminary report. Lav 1st Anat Isotol Patol Perugia 1966; 26: 149–156
- Simons P J, McCully D J. Pathologic and virologic studies of tumors induced in mice by two strains of murine sarcoma virus. J Natl Cancer Inst 1970; 44: 1289–1303
- Soong M M, Yuen P H, Wong P K. Isolation and characterization of a Mo‐MuSV‐transformed TB cell line that produces noninfectious MuSV particles with uncleaved gag protein which is processed in the presence of Mo‐MuLV. Virology 1984; 132: 390–400
- Stanton M F, Law L W, Ting R C. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. II. Morphologic studies. J Natl Cancer Inst 1968; 40: 1113–1129
- Stoica G, Hoffman J, Yuen P H. Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in BALB/c mice. Am J Pathol 1990; 136: 933–947
- Szurek P F, Yuen P H, Jerzy R, Wong P K. Identification of point mutations in the envelope gene of Moloney murine leukemia virus TB temperature‐sensitive paralytogenic mutant tsl: molecular determinants for neurovirulence. J Virol 1988; 62: 357–360
- Wong P K, Soong M M, Yuen P H. Replication of murine leukemia virus in heterologous cells: interaction between ecotropic and xenotropic viruses. Virology 1981; 109: 366–378
- Yuen P H, Kwak Y T. R7, a spontaneous mutant of Moloney murine sarcoma virus 124 with three direct repeats and an in‐frame truncated gag‐mos gene, induces brain lesions. Virology 1997; 236: 213–218
- Yuen P H, Kwak Y T. Studies on the pathology, especially brain lesions, induced by R7, a spontaneous mutant of Moloney murine sarcoma virus 124. Am J Pathol 1998; 152: 1509–1520
- Yuen P H, Malehom D, Nau C, Soong M M, Wong P K. Molecular cloning of two paralytogenic, temperature‐sensitive mutants, tsl and ts7, and the parental wild‐type Moloney murine leukemia virus. J Virol 1985; 54: 178–185
- Yuen P H, Matheme C M, Molinari‐Storey L M. SV7, a molecular clone of Moloney murine sarcoma virus 349, transforms vascular endothelial cells. Am J Pathol 1991; 139: 1449–1461
- Yuen P H, Szurek P F. The reduced virulence of the thymotropic Moloney murine leukemia virus derivative MoMuLV.‐TB is mapp ed to 11 mutations within the U3 region of the long terminal repeat. J Virol 1989; 63: 471–480